Literature DB >> 9509184

Directly observed therapy for tuberculosis given twice weekly in the workplace in urban South Africa.

S Bechan1, C Connolly, G M Short, E Standing, D Wilkinson.   

Abstract

Effective models of delivery of directly observed therapy (DOT) for tuberculosis in resource-poor settings are needed. Intermittent chemotherapy may be an important component of DOT delivered in the community as it means fewer visits to supervisors. There is no published evidence on the efficacy of twice weekly therapy given from the start of treatment without an intensive daily phase. We analysed data from 3 large cohort studies in a migrant, urban workforce in South Africa between 1975 and 1983. All patients received 4 drugs (isoniazid, rifampicin, pyrazinamide and streptomycin) twice weekly under direct observation by a nurse in the workplace. Of 444 patients, 378 (85.1%) completed treatment. Cure could be assessed in 362, and 348 (96.1%, 95% confidence interval 93.7-97.8%) were bacteriologically cured. Sputum status was assessed at 2-3 months in 343 patients and 309 (90.1%) were sputum negative. Eighteen patients relapsed (5.7%; 2.9/100 patient-years of observation). DOT can be effectively delivered to a migrant, urban workforce, and 4-drug therapy given twice weekly under direct observation is efficacious.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Demographic Factors; Developing Countries; Diseases; Drugs; Economic Factors; Employment-based Services; English Speaking Africa; Evaluation; Human Resources; Infections; Labor Force; Migrant Workers; Monitoring; Organization And Administration; Population; Population Characteristics; Programs; Research Report; South Africa; Southern Africa; Treatment; Tuberculosis; Urban Population

Mesh:

Substances:

Year:  1997        PMID: 9509184     DOI: 10.1016/s0035-9203(97)90532-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

Review 1.  Directly observed therapy (DOT) for tuberculosis: why, when, how and if?

Authors:  L P Ormerod
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration.

Authors:  J L Johnson; A Okwera; P Nsubuga; J G Nakibali; C C Whalen; D Hom; M D Cave; Z H Yang; R D Mugerwa; J J Ellner
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

3.  Potential of rapid diagnosis for controlling drug-susceptible and drug-resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent.

Authors:  Pieter W Uys; Robin Warren; Paul D van Helden; Megan Murray; Thomas C Victor
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

4.  It's complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa.

Authors:  Donald Skinner; Mareli Claassens
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.